Antibodies is an international, peer-reviewed, open access journal on immunoglobulins, published quarterly online by MDPI.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within Scopus, ESCI (Web of Science), PubMed, PMC, Embase, CAPlus / SciFinder, and other databases.
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 17.8 days after submission; acceptance to publication is undertaken in 3.8 days (median values for papers published in this journal in the second half of 2022).
  • Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Add your e-mail address to receive forthcoming issues of this journal:
Topic in Antibodies, COVID, Pathogens, Vaccines, Viruses
Host Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development Topic Editors: Fabrizio Angius, Meng Ling Moi
Deadline: 31 August 2023
Special Issue in Antibodies
SARS-CoV-2: Immune Response Elicited by Infection or Vaccination Guest Editor: Elisa Pesce
Deadline: 20 June 2023
Special Issue in Antibodies
Novel Strategies and Technologies for the Development of Tumor-Specific Antibodies Guest Editor: Alexander J. Bankovich
Deadline: 15 July 2023
Special Issue in Antibodies
Coronavirus-Targeting Antibodies Guest Editors: George Carnell, Nigel Temperton
Deadline: 1 August 2023
Special Issue in Antibodies
Antibody Effector Functions in Parasitic Diseases Guest Editor: Farhat Afrin
Deadline: 20 August 2023
Topical Collection in Antibodies
Computational Antibody and Antigen Design Collection Editor: Buyong Ma
Back to TopTop